Annual Current Liabilities
$1.05 M
+$763.50 K+266.49%
December 31, 2022
Summary
- As of February 10, 2025, DALS annual total current liabilities is $1.05 million, with the most recent change of +$763.50 thousand (+266.49%) on December 31, 2022.
- During the last 3 years, DALS annual current liabilities has risen by +$763.50 thousand (+266.49%).
Performance
DALS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$1.35 M
+$303.00 K+28.86%
March 31, 2023
Summary
- As of February 10, 2025, DALS quarterly total current liabilities is $1.35 million, with the most recent change of +$303.00 thousand (+28.86%) on March 31, 2023.
- Over the past year, DALS quarterly current liabilities has increased by +$1.05 million (+340.72%).
Performance
DALS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
DALS Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +266.5% | +340.7% |
3 y3 years | +266.5% | +1792.3% |
5 y5 years | +266.5% | +1792.3% |
DALS Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -72.7% | at high | -77.6% |
5 y | 5-year | at high | -72.7% | at high | -94.7% |
alltime | all time | at high | -72.7% | at high | -94.7% |
DA32 Life Science Tech Acquisition Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2023 | - | $1.35 M(+28.9%) |
Dec 2022 | $1.05 M(+266.5%) | $1.05 M(+79.8%) |
Sep 2022 | - | $584.00 K(+92.5%) |
Jun 2022 | - | $303.30 K(-1.2%) |
Mar 2022 | - | $307.00 K |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $286.50 K | - |
Sep 2021 | - | $216.80 K(+68.6%) |
Jul 2021 | - | $128.60 K(-73.7%) |
Jun 2021 | - | $488.80 K(+583.6%) |
Apr 2021 | - | $71.50 K |
FAQ
- What is DA32 Life Science Tech Acquisition annual total current liabilities?
- What is the all time high annual current liabilities for DA32 Life Science Tech Acquisition?
- What is DA32 Life Science Tech Acquisition annual current liabilities year-on-year change?
- What is DA32 Life Science Tech Acquisition quarterly total current liabilities?
- What is the all time high quarterly current liabilities for DA32 Life Science Tech Acquisition?
- What is DA32 Life Science Tech Acquisition quarterly current liabilities year-on-year change?
What is DA32 Life Science Tech Acquisition annual total current liabilities?
The current annual current liabilities of DALS is $1.05 M
What is the all time high annual current liabilities for DA32 Life Science Tech Acquisition?
DA32 Life Science Tech Acquisition all-time high annual total current liabilities is $1.05 M
What is DA32 Life Science Tech Acquisition annual current liabilities year-on-year change?
Over the past year, DALS annual total current liabilities has changed by +$763.50 K (+266.49%)
What is DA32 Life Science Tech Acquisition quarterly total current liabilities?
The current quarterly current liabilities of DALS is $1.35 M
What is the all time high quarterly current liabilities for DA32 Life Science Tech Acquisition?
DA32 Life Science Tech Acquisition all-time high quarterly total current liabilities is $1.35 M
What is DA32 Life Science Tech Acquisition quarterly current liabilities year-on-year change?
Over the past year, DALS quarterly total current liabilities has changed by +$1.05 M (+340.72%)